Group 1 - The Shanghai Stock Exchange has approved Guotai Haitong Securities Co., Ltd. to provide primary market-making services for the Zhongyao ETF starting from March 11, 2026 [1] - The approval is aimed at enhancing the market liquidity and stable operation of the Zhongyao ETF, which is focused on traditional Chinese medicine [1] - The decision is in accordance with the relevant regulations outlined in the Shanghai Stock Exchange's self-regulatory guidelines for fund market-making [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 特此公告。 上海证券交易所 2026年03月10日 上证公告（基金）【2026】486号 为促进华夏中证港股通消费主题交易型开放式指数证券投资基金（以下简称H股消费，基金代 码:513230）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意国泰海通证券股份有限公司自2026年03月11日起为H股消费提 供主做市服务。 ...

Group 1 - The announcement states that the Shanghai Stock Exchange has approved Guotai Haitong Securities Co., Ltd. to provide primary market-making services for the Bosera CSI Financial Technology Theme Exchange-Traded Fund (ETF) starting from March 11, 2026 [1][2][3] - The purpose of this approval is to enhance the market liquidity and stable operation of the financial technology ETF [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 2026年03月10日 上证公告（基金）【2026】485号 为促进华安CES港股通精选100交易型开放式指数证券投资基金（以下简称港股100，基金代 码:513900）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意国泰海通证券股份有限公司自2026年03月11日起为港股100提 供主做市服务。 上海证券交易所 特此公告。 ...

Core Viewpoint - ST Huapeng experienced a significant increase in stock price, rising by 4.86% on March 10, with a closing price of 7.77 yuan and a total market capitalization of 2.486 billion yuan [1][5]. Trading Activity - The stock was listed on the "Dragon and Tiger List" due to a cumulative price deviation of 12% over three consecutive trading days [1][5]. - Total buying amounted to 41.10 million yuan, while total selling reached 45.51 million yuan, resulting in a net sell of 4.42 million yuan [1][5]. - Major buying firms included Guotai Junan Securities Headquarters (12.34 million yuan), CITIC Securities Shanghai Yingkou Road (11.03 million yuan), and Industrial Securities Qingdao Branch (7.83 million yuan) [1][5]. - Major selling firms included UBS Securities Shanghai Huayuan Shiqiao Road (11.42 million yuan), Guotai Junan Securities Headquarters (11.12 million yuan), and CITIC Securities Shanghai Yingkou Road (8.95 million yuan) [1][5]. Company Overview - Shandong Huapeng Glass Co., Ltd. was established on December 29, 2001, and listed on April 23, 2015. The company specializes in the research, production, and sales of glassware and glass bottles [3][7]. - The main revenue sources are glass bottles (85.74%), glassware (13.67%), and other products (0.59%) [3][7]. - The company is classified under the light industry manufacturing sector, specifically in home goods [3][7]. Financial Performance - As of September 30, the number of shareholders was 11,100, a decrease of 25.60% from the previous period, while the average circulating shares per person increased by 34.42% to 28,863 shares [4][8]. - For the period from January to September 2025, ST Huapeng reported revenue of 271 million yuan, a year-on-year decrease of 6.07%, and a net profit attributable to shareholders of -96.05 million yuan, a year-on-year increase of 1.24% [4][8]. - The company has distributed a total of 77.69 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [4][9].

Group 1 - The core viewpoint of the report is that the company maintains a "buy" rating for Mengniu Dairy (02319), with projected revenues for 2025-2027 at 82.21 billion, 85.01 billion, and 88.63 billion yuan, and net profits of 1.53 billion, 4.51 billion, and 5.39 billion yuan respectively, leading to an EPS of 0.39, 1.16, and 1.39 yuan per share [1] - The liquid milk segment has shown a quarter-on-quarter recovery, with other product categories also experiencing strong growth, including fresh milk, milk powder, and cheese, all expected to achieve double-digit growth in 2025 [1] - The company is focusing on product iteration and innovation, promoting diversified business development [1] Group 2 - The company plans to recognize impairment provisions totaling 2.2 to 2.4 billion yuan for certain idle production facilities, receivables, and entrusted loans, with an expected net profit of 1.4 to 1.6 billion yuan for the year, compared to 100 million yuan in the previous year [2] - Continuous management optimization and cost control efforts are being made, alongside increased investment in R&D and digitalization to enhance operational efficiency, with an expected operating profit margin of 7.9% to 8.1% [2] - The raw milk price is stabilizing, benefiting from a reduction in supply due to a backlog in heifer stocking and diminished import impacts, with a strong upward trend in milk prices expected in 2026 [2]

Core Viewpoint - Cathay Securities initiates coverage on Fosun International (00656) with a "Buy" rating and a target price of HKD 7.24, indicating a significant upside potential based on the company's NAV of HKD 18.1 per share and total NAV of HKD 147.8 billion [1] Group 1: Business Structure and Performance - The company focuses on family users globally, providing services across four main sectors: health, happiness, wealth, and smart manufacturing [1] - The wealth sector, primarily through Fosun Portugal Insurance, contributes stable income with a leading market share in Portugal [1] - The happiness sector includes vacation, cultural consumption, and fashion brands, with Fosun Tourism achieving record revenue and ongoing cost reduction [1] - The health sector, centered on Fosun Pharma (02196), shows continuous improvement in innovative drug contributions and significant updates across multiple pipelines [1] - The smart manufacturing sector targets emerging industries, focusing on strategic resources and new materials to enable high-end, intelligent, and green transformations [1] Group 2: Financial Health and Strategy - Fosun International has effectively streamlined operations, focusing on debt reduction and exiting non-core assets for four consecutive years, leading to improved asset quality and reduced financial leverage [2] - The company has maintained a stable credit rating of BB- from S&P, indicating potential for recovery through strategic focus on market-leading core businesses and global operations [2] Group 3: Catalysts - The macroeconomic environment is showing signs of recovery, which could positively impact the company's performance [3] - Accelerated approval and market entry of innovative drugs may serve as a significant growth driver for the health sector [3]

Core Viewpoint - GCL-Poly Energy Holdings Limited (协鑫能科) experienced a significant stock price increase, reaching a daily limit up with a closing price of 17.18 yuan and a total market capitalization of 27.889 billion yuan on March 9 [1][9]. Trading Activity - On March 9, GCL-Poly's stock was featured on the "龙虎榜" due to a price deviation of over 7% and a cumulative deviation of 20% over three consecutive trading days [1][9]. - The total buy amount on that day was 299 million yuan, while the total sell amount was 335 million yuan, resulting in a net sell of 36.27 million yuan [1][9]. - Major buying activities were recorded from institutions such as Guotai Junan Securities and East Asia Qianhai Securities, with significant sell-offs from Guotai Junan Securities in Jiangyin [1][2][3]. Financial Performance - For the period from January to September 2025, GCL-Poly reported a revenue of 7.935 billion yuan, reflecting a year-on-year growth of 5.07%, and a net profit attributable to shareholders of 762 million yuan, which is a 25.78% increase compared to the previous year [6][14]. - The company's main revenue sources include electricity sales (42.85%), heat sales (17.79%), and energy services (16.60%) [6][14]. Shareholder Structure - As of September 30, 2025, GCL-Poly had 78,000 shareholders, a decrease of 15.41% from the previous period, with an average of 20,802 circulating shares per shareholder, an increase of 18.21% [6][14]. - Notable changes in the top ten shareholders include a decrease in holdings by Hong Kong Central Clearing Limited and the entry of Guangfa Balanced Preferred Mixed Fund as a new shareholder [7][15]. Market Position - GCL-Poly operates in the clean energy sector, focusing on clean energy operations, mobile energy operations, and comprehensive energy services, with its business segments including hydropower, biomass energy, and offshore wind power [6][14].

Core Viewpoint - Cathay Securities initiates coverage on Tianhong International Group (02678) with a "Buy" rating, highlighting its position as a global leader in yarn production and its strategic early investment in Vietnam, which has resulted in mature production capacity. The firm anticipates that the company's high inventory levels are nearly cleared, leading to a profit upturn [1] Group 1: Company Overview - Tianhong International Group, founded in 1997, is one of the largest suppliers of core-spun cotton textiles globally. The company has proactively expanded its yarn production capacity in Vietnam since 2006, successfully navigating challenges such as rising cotton prices and supply chain disruptions [1] - The founder and controlling shareholder, Mr. Hong Tianzhu, holds a 52.9% stake, indicating a concentrated ownership among core executives [1] Group 2: Financial Performance - The company’s cost structure is heavily influenced by raw material prices, with 76.1% of costs attributed to cotton. It is expected to maintain a cotton inventory for 3-4 months, leading to cyclical profit fluctuations based on cotton price trends. In 2024, the company is projected to benefit from brand restocking and has successfully returned to profitability [2] - Forecasted net profits for the company are expected to reach 0.89 billion, 1.04 billion, and 1.13 billion yuan for the years 2025, 2026, and 2027, respectively, with a target price of 10.20 HKD based on a PE ratio of 8X for 2026 [1] Group 3: Industry Outlook - The global yarn market is projected to grow from 845.66 billion yuan in 2025 to 1,260.29 billion yuan by 2032, with a CAGR of 5.9%. Tianhong International Group's yarn revenue is expected to be 17.91 billion yuan in 2024, accounting for 2.1% of the market [3] Group 4: Future Prospects - The company is in an active debt repayment phase, which is expected to reduce financial expenses and enhance profits. It is projected to repay 0.8-1 billion yuan annually from 2025 to 2027, leading to interest savings of 0.13 billion, 0.05 billion, and 0.04 billion yuan, respectively [4] - The trend towards diversified sourcing and increased brand traceability requirements presents opportunities for market share growth. The company’s established overseas production capacity positions it favorably to secure more orders [4] - Internal technological upgrades and investments in solar energy are anticipated to drive organic growth. The wage component per unit of revenue has decreased from 0.084 yuan in 2017 to 0.075 yuan in 2024, with plans to build a 180 MW solar power station by 2025, which is expected to lower overall production costs [4]

Core Viewpoint - Cathay Securities maintains a "Buy" rating for China Tobacco Hong Kong (06055) and raises the EPS forecast for 2026-2027 to HKD 1.64/1.95 from HKD 1.58/1.75, with a target price of HKD 44 based on a 27X PE for 2026, considering the company's growth potential and expansion logic [1] Group 1: Financial Performance - The company expects a stable performance in 2025, with projected revenue of HKD 14.58 billion, a year-on-year increase of 11.5%, and a net profit of HKD 980 million, up 14.8%, with a gross margin of 10.1%, down 0.4 percentage points [1] - For the second half of 2025, revenue is anticipated to be HKD 4.26 billion, down 2.5%, while net profit is expected to rise by 30.2% to HKD 270 million, suggesting a need to view the full year performance collectively [1] - Shareholder returns are projected with dividends of HKD 0.32/0.46/0.52 per share for 2023-2025, maintaining a payout ratio of around 37% [1] Group 2: Revenue Breakdown - For 2025, the revenue from imported tobacco leaf products is expected to be HKD 9.54 billion, a year-on-year increase of 15.6%, with a decrease in gross margin by 1.9 percentage points due to increased costs from Brazilian tobacco leaf procurement [2] - Revenue from exported tobacco leaf products is projected at HKD 2.48 billion, up 20.4%, with a gross margin increase of 2.2 percentage points, benefiting from price increases [2] - Revenue from cigarette exports is expected to reach HKD 1.67 billion, a 5.9% increase, with a gross margin improvement of 5.2 percentage points to 22.8%, driven by a higher proportion of duty-free self-operated sales [2] - New tobacco product exports are projected to decline significantly by 52.4% to HKD 60 million, primarily due to international events [2] - The Brazilian operations are expected to generate HKD 830 million, down 21.0%, influenced by both volume and price declines [2] Group 3: Strategic Initiatives - The company is actively expanding its business by integrating resources and exploring new markets, with changes in tobacco leaf and cigarette export operations expected in 2026 [3] - The company has initiated tobacco leaf procurement from China Tobacco North America and sales to third parties, with expected transaction limits significantly higher than in 2025 [3] - As the only state-owned enterprise with the qualification to export cigarettes to the domestic duty-free market, China Tobacco Hong Kong is expected to enhance its revenue and profitability through collaboration with China Tobacco International [3]